Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Levetiracetam (Keppra) Tolerability and Efficacy in Cocaine Abusing Methadone-maintained Patients.

NCT00593125 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT00593125
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00593125 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Levetiracetam (Keppra) Tolerability and Efficacy in Cocaine Abusing Methadone-maintained Patients.
Lead sponsor
Yale University
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2007
Completion date
August 31, 2008
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cocaine dependence, opioid dependence